Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Currently, Yuyu Pharma has two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. Yuyu Pharma also has various Over-the-counter drugs and dietary supplements, such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins)
View Top Employees from Yuyu PharmaWebsite | http://www.yuyu.co.kr/en |
Revenue | $57 million |
Employees | 158 (73 on RocketReach) |
Founded | 1941 |
Address | 54, Buil-ro 205beon-gil, Bucheon-si, Gyeonggi-do, KR |
Phone | +82 2-2253-6600 |
Fax | +82 2-2253-6200 |
Technologies |
JavaScript,
HTML,
PHP
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Web Rank | 2 Million |
Keywords | Pharmaceutical Products, Medical Devices, Osteoporosis Treatment |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Yuyu Pharma employee's phone or email?
The Yuyu Pharma annual revenue was $57 million in 2024.
Laxmikant Gharat is the Vice President and Head, Business Development, New Drug Discovery of Yuyu Pharma.
73 people are employed at Yuyu Pharma.
Yuyu Pharma is based in Bucheon-si, Gyeonggi-do.
The NAICS codes for Yuyu Pharma are [32541, 32, 3254, 325].
The SIC codes for Yuyu Pharma are [283, 28].